Apollomics (APLM) Institutional Ownership $28.08 -1.10 (-3.77%) Closing price 10/23/2025 03:57 PM EasternExtended Trading$27.84 -0.24 (-0.87%) As of 10/23/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Apollomics (NASDAQ:APLM)CurrentInstitutional OwnershipPercentage19.13%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$12.15M Get APLM Insider Trade Alerts Want to know when executives and insiders are buying or selling Apollomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data APLM Institutional Buying and Selling by Quarter Apollomics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/21/2025Exchange Traded Concepts LLC12,592$127K0.0%-99.0%1.155% 10/10/2024Exchange Traded Concepts LLC1,259,117$179K0.0%+247.1%1.407% 8/2/2024George Kaiser Family Foundation670,976$141K0.0%+2,585.6%0.750% 4/16/2024Powell Investment Advisors LLC130,297$98K0.1%N/A0.146% 11/13/2023George Kaiser Family Foundation24,984$94K0.0%-96.3%0.029% 7/31/2023Levin Capital Strategies L.P.11,000$62K0.0%N/A0.013% 7/20/2023Exchange Traded Concepts LLC29,552$166K0.0%N/A0.034% 5/12/2023Clear Street LLC6,800$165K0.0%N/A0.008% 5/10/2023George Kaiser Family Foundation670,976$16.24M2.6%N/A0.773% (Data available from 1/1/2016 forward) APLM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APLM shares? During the previous two years, the following institutional investors and hedge funds held shares of Apollomics shares: George Kaiser Family Foundation ($141K), and Exchange Traded Concepts LLC ($127K), Powell Investment Advisors LLC ($98K).Learn more on Apollomics' institutional investors. What percentage of Apollomics' stock is owned by institutional investors? 19.13% of Apollomics' stock is owned by institutional investors. Learn more on APLM's institutional investor holdings. Which institutional investors have been buying Apollomics' stock? The following institutional investors have purchased Apollomics' stock in the last 24 months: Exchange Traded Concepts LLC ($896.32K), George Kaiser Family Foundation ($645.99K), and Powell Investment Advisors LLC ($130.30K). Which of Apollomics' major shareholders have been selling company stock? The following institutional investors have sold Apollomics stock in the last 24 months: Exchange Traded Concepts LLC ($1.25M). How much institutional selling is happening at Apollomics? Institutional investors have sold a total of 1,246,525 shares in the last 24 months. This volume of shares sold represents approximately $12.15M in transactions. Related Companies Invizyne Technologies Institutional Ownership Unicycive Therapeutics Institutional Ownership Repare Therapeutics Institutional Ownership Vaxart Institutional Ownership XBiotech Institutional Ownership Werewolf Therapeutics Institutional Ownership CervoMed Institutional Ownership PMV Pharmaceuticals Institutional Ownership Equillium Institutional Ownership Prelude Therapeutics Institutional Ownership This page (NASDAQ:APLM) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLM Stock Alerts